SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Prospector who wrote (3602)7/31/1998 1:16:00 PM
From: Prospector  Read Replies (1) of 5402
 
Mr DuGen

I have to retract that last post I am wrong ,, I just called Dr Drees for varifacation.. Flousol or the Japanese first generation drug took 10 years to get FDA approval. There were alot of hurdles that had to be gone over.. One is which was using liquid Teflon as a blood substitute.. most drugs that go through testing take between 10 to 20 years to get FDA approval.

The important thing to remember here is that PHER-02 is a (SECOND GENERATION DRUG) .. Dr Drees thinks it will be through the FDA approval from animal testing to human testing in 36 months..

Prospector
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News